Lateral habenula as a link between dopaminergic and serotonergic systems contributes to depressive symptoms in Parkinson's disease

Brain Research Bulletin

Volumn 110, Issue , 2015, Pages 40-46

  Luo, Xiao Feng ^a   Zhang, Bei Lin ^a   Li, Ji Cheng ^a   Yang, Ying Ying ^a   Sun, Yan Fei ^a   Zhao, Hua ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

6 hydropamine rat model; Depressive like behavior; Lateral habenula; Raphe nuclei; Serotonin; Substantia nigra

Indexed keywords

CYTOCHROME C OXIDASE; SEROTONIN; ASCORBIC ACID; DOPAMINE; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CLIMBING; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; FORCED SWIM TEST; HABENULA; IMMOBILITY; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; PARKINSON DISEASE; PATHOGENESIS; RAPHE NUCLEUS; RAT; SEROTONIN BLOOD LEVEL; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SUBSTANTIA NIGRA; ANIMAL; ELECTROSTIMULATION; EXPLORATORY BEHAVIOR; METABOLISM; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PARKINSONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; ASCORBIC ACID; DEPRESSIVE DISORDER; DOPAMINE; ELECTRIC STIMULATION; ELECTRON TRANSPORT COMPLEX IV; EXPLORATORY BEHAVIOR; HABENULA; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RANDOM ALLOCATION; RAPHE NUCLEI; RATS, WISTAR; SEROTONIN;

EID: 84918833202     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.11.006     Document Type: Article

References (47)

1. Adell A., Celada P., Abellán M.T., Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. 2002, 39:154-180.
2. Aghajanian G.K., Wang R.Y. Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Res. 1977, 122:229-242.
3. Aizawa H., Kobayashi M., Tanaka S., Fukai T., Okamoto H. Molecular characterization of the subnuclei in rat habenula. J. Comp. Neurol. 2012, 520:4051-4066.
4. Aizawa H., Yanagihara S., Kobayashi M., Niisato K., Takekawa T., Harukuni R., McHugh T.J., Fukai T., Isomura Y., Okamoto H. The synchronous activity of lateral habenular neurons is essential for regulating hippocampal theta oscillation. J. Neurosci. 2013, 33:8909-8921.
5. Armario A., Gavaldà A., Martí O. Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate. Eur. J. Pharmacol. 1988, 158:207-212.
6. Bastide M.F., Dovero S., Charron G., Porras G., Gross C.E., Fernagut P.O., Bézard E. Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia. Neurobiol. Dis. 2014, 62:179-192.
7. Caldecott-Hazard S., Mazziotta J., Phelps M. Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. J. Neurosci. 1988, 8:1951-1961.
8. Carod-Artal F.J., Vargas A.P., Martinez-Martin P. Determinants of quality of life in Brazilian patients with Parkinson's disease. Mov. Disord. 2007, 22:1408-1415.
9. Devos D., Dujardin K., Poirot I., Moreau C., Cottencin O., Thomas P., Destée A., Bordet R., Defebvre L. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov. Disord. 2008, 23:850-857.
10. Gray N.A., Milak M.S., DeLorenzo C., Ogden R.T., Huang Y.Y., Mann J.J., Parsey R.V. Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. Biol. Psychiatry 2013, 74:26-31.
11. Herkenham M., Nauta W.J. Efferent connections of the habenular nuclei in the rat. J. Comp. Neurol. 1979, 187:19-47.
12. Hikosaka O. The habenula: from stress evasion to value-based decision-making. Nat. Rev. Neurosci. 2010, 11:503-513.
13. Hong S., Hikosaka O. The globus pallidus sends reward-related signals to the lateral habenula. Neuron 2008, 60:720-729.
14. Hong S., Hikosaka O. Diverse sources of reward value signals in the basal ganglia nuclei transmitted to the lateral habenula in the monkey. Front. Hum. Neurosci. 2013, 7:778.
15. Jacobsen J.P., Medvedev I.O., Caron M.G. The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2012, 367:2444-2459.
16. Katz R.J., Roth K.A., Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci. Biobehav. 1981, 5:247-251.
17. Lecourtier L., Neijt H.C., Kelly P.H. Habenula lesions cause impaired cognitive performance in rats: implications for schizophrenia. Eur. J. Neurosci. 2004, 19:2551-2560.
18. Matsumoto M., Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 2007, 447:1111-1115.
19. Mayeux R., Stern Y., Cote L., Williams J.B. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984, 34:642-646.
20. Mayeux R., Stern Y., Williams J.B., Cote L., Frantz A., Dyrenfurth I. Clinical and biochemical features of depression in Parkinson's disease. Am. J. Psychiatry 1986, 143:756-759.
21. McCulloch J., Savaki H.E., Sokoloff L. Influence of dopaminergic systems on the lateral habenular nucleus of the rat. Brain Res. 1980, 194:117-124.
22. McDonald W.M., Richard I.H., DeLong M.R. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol. Psychiatry 2003, 54:363-375.
23. Morris J.S., Smith K.A., Cowen P.J., Friston K.J., Dolan R.J. Covariation of activity in habenula and dorsal raphé nuclei following tryptophan depletion. Neuroimage 1999, 10:163-172.
24. Paulus W., Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J. Neuropathol. Exp. Neurol. 1991, 50:743-755.
25. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, USA. fourth ed.
26. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978, 47:379-391.
27. Rahman S., Griffin H.J., Quinn N.P., Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov. Disord. 2008, 23:1428-1434.
28. Sartorius A., Kiening K.L., Kirsch P., von Gall C.C., Haberkorn U., Unterberg A.W., Henn F.A., Meyer-Lindenberg A. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol. Psychiatry 2010, 67:9-11.
29. Scatton B., Javoy-Agid F., Rouquier L., Dubois B., Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 1983, 275:321-328.
30. Shelton L., Pendse G., Maleki N., Moulton E.A., Lebel A., Becerra L., Borsook D. Mapping pain activation and connectivity of the human habenula. J. Neurophysiol. 2012, 107:2633-2648.
31. Shen X., Ruan X., Zhao H. Stimulation of midbrain dopaminergic structures modifies firing rates of rat lateral habenula neurons. PLoS ONE 2012, 7:e34323.
32. Shulman L.M., Taback R.L., Bean J., Weiner W.J. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov. Disord. 2001, 16:507-510.
33. Shumake J., Edwards E., Gonzalez-Lima F. Opposite metabolic changes in the habenula and ventral tegmental area of a genetic model of helpless behavior. Brain Res. 2003, 963:274-281.
34. Sourani D., Eitan R., Gordon N., Goelman G. The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease. Eur. J. Neurosci. 2012, 36:2822-2829.
35. Stern W.C., Johnson A., Bronzino J.D., Morgane P.J. Effects of electrical stimulation of the lateral habenula on single-unit activity of raphe neurons. Exp. Neurol. 1979, 65:326-342.
36. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 1998, 18:7394-7401.
37. Tadaiesky M.T., Dombrowski P.A., Figueiredo C.P., Cargnin-Ferreira E., Da Cunha C., Takahashi R.N. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. Neuroscience 2008, 156:830-840.
38. Tanabe A., Nomura S. Pathophysiology of depression. Nihon Rinsho 2007, 65:1585-1590.
39. Truong L., Allbutt H., Kassiou M., Henderson J.M. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions. Behav. Brain Res. 2006, 169:1-9.
40. Trugman J.M., James C.L., Wooten G.F. D1/D2 dopamine receptor stimulation by L-dopa. A [14C]-2-deoxyglucose autoradiographic study. Brain 1991, 114:1429-1440.
41. Varga V., Kocsis B., Sharp T. Electrophysiological evidence for convergence of inputs from the medial prefrontal cortex and lateral habenula on single neurons in the dorsal raphe nucleus. Eur. J. Neurosci. 2003, 17:280-286.
42. Wong-Riley M.T. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 1989, 12:94-101.
43. Wooten G.F., Collins R.C. Metabolic effects of unilateral lesion of the substantia nigra. J. Neurosci. 1981, 1:285-291.
44. Yalcin I., Coubard S., Bodard S., Chalon S., Belzung C. Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice. Psychopharmacology (Berl) 2008, 200:497-507.
45. Yang L.M., Hu B., Xia Y.H., Zhang B.L., Zhao H. Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus. Behav. Brain Res. 2008, 188:84-90.
46. Zhao H., Rusak B. Circadian firing-rate rhythms and light responses of rat habenular nucleus neurons in vivo and in vitro. Neuroscience 2005, 132:519-528.
47. Zibetti M., Merola A., Artusi C.A., Rizzi L., Angrisano S., Reggio D., De Angelis C., Rizzone M., Lopiano L. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience. Eur. J. Neurol. 2013, 7:132-154.